Every 10-Q that Omega Healthcare (OHI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow OHI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OHI filings page.
Omega Healthcare Investors, Inc. reported second-quarter 2026 revenues of $328.2 million, up from $282.5 million a year earlier. Net income rose to $379.7 million from $140.5 million, and net income available to common stockholders increased to $362.8 million (diluted EPS $1.19 vs. $0.46), largely boosted by a $246.5 million gain on asset sales.
For the first six months of 2026, revenues were $651.2 million and net income available to common stockholders was $513.9 million. Omega sold 30 facilities for $597.1 million in consideration, including a major CommuniCare portfolio transaction, while acquiring 23 facilities for $236.3 million and investing in construction and capital improvements. Operating cash flow was $433.2 million, and total assets were $10.0 billion with total equity of $5.6 billion.
The company introduced a new Operating segment using the RIDEA structure alongside its existing Triple-Net segment, continued to manage credit exposures to Maplewood and Genesis, and maintained common dividends of $0.67 per share in February and May 2026, with a $0.68 dividend declared for August 2026. Leadership changes include a planned CEO transition on October 1, 2026 and a CFO transition on August 1, 2026, contributing to higher stock-based compensation expense.
Omega Healthcare Investors reported stronger first‑quarter 2026 results, with higher revenue and earnings while actively recycling assets and managing operator exposure. Total revenues rose to $322.9M from $276.8M a year earlier, driven mainly by rental income growth and new senior housing operating revenue.
Net income available to common stockholders increased to $151.0M, or $0.47 per diluted share, up from $109.0M and $0.33 per share. Operating cash flow improved to $215.5M. Omega invested $126.4M in new real estate, including 13 SNFs in Georgia, and sold four SNFs for $34.5M in proceeds.
The company expanded its held‑for‑sale pool to 19 facilities and post‑quarter sold 12 CommuniCare‑leased facilities in Maryland for $326.3M, reallocating capital while reducing single‑operator concentration. Omega ended the quarter with total assets of $10.23B, net real estate loans of $1.39B, and unsecured borrowings of about $4.44B, including $425M drawn on its revolver.
Omega Healthcare Investors (OHI) reported stronger Q3 results. Total revenue rose to $311.6 million from $276.0 million a year ago, and diluted EPS increased to $0.59 from $0.42. Net income was $185.0 million versus $114.9 million. For the first nine months, revenue reached $870.9 million compared with $772.1 million last year, and net income was $437.5 million.
Omega was active on both acquisitions and dispositions. Year‑to‑date, it acquired 66 facilities for $637.9 million across the U.S., U.K. and Jersey, generally at initial cash yields around 10%. It sold 45 facilities for $264.1 million, recognizing $61.2 million of net gains. The company recorded $16.6 million of impairments year‑to‑date. In February, the $201.8 million Inspir Embassy Row ALF was placed into service, contributing $3.3 million of Q3 rent. Operating cash flow for the first nine months was $647.9 million, ending Q3 with $737.2 million in cash. Common shares outstanding were 295.5 million, and dividends declared were $0.67 per share in Q3 (year‑to‑date $2.01).